Position in NUVB
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,214,525
-$140,153 QoQ
Shares Held
213,825
-32.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. NUVB ranks #135 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,214,525 | 213,825 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $1,354,678 | 315,776 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $565,214 | 63,082 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,414,718 | 922,897 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,579,574 | 1,322,859 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,313,124 | 746,094 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,268,327 | 852,755 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,904,235 | 831,544 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,124,965 | 727,728 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $2,567,673 | 705,405 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,594,648 | 1,056,059 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,732 | 1,293 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $126,719 | 70,400 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $62,206 | 37,474 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $32,167 | 16,754 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $52,073 | 23,247 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $94,918 | 29,296 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $200,067 | 38,036 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $373,167 | 43,902 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $293,448 | 29,522 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $134,529 | 14,450 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||